National Research Corporation (NASDAQ:NRC – Get Free Report) announced a quarterly dividend on Tuesday, October 27th. Shareholders of record on Tuesday, December 29th will be given a dividend of $0.16 per share on Friday, January 8th. This represents a $0.64 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, December 29th.
National Research has raised its dividend payment by an average of 0.2% per year over the last three years.
National Research Stock Down 3.1%
Shares of NASDAQ NRC opened at $21.75 on Wednesday. The firm’s 50 day simple moving average is $21.12 and its 200-day simple moving average is $19.15. National Research has a 12 month low of $11.43 and a 12 month high of $23.68.
National Research (NASDAQ:NRC – Get Free Report) last posted its earnings results on Tuesday, October 27th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.03. The firm had revenue of $38.40 million for the quarter, compared to analysts’ expectations of $35.80 million. Equities analysts predict that National Research will post 0.98 EPS for the current fiscal year.
National Research Company Profile
National Research Corporation, formerly traded on the Nasdaq under the symbol NRC, provides research, analytics and performance-improvement services to the health care industry. Through its NRC Health business, the company helps hospitals, health systems and other care organizations understand and improve patient, consumer and employee experiences.
Its offerings have included patient and employee surveys, market research, reputation management, loyalty and engagement programs, benchmarking, and software tools that turn feedback and other data into operational insights.
Further Reading
- Five stocks we like better than National Research
- Is United Parcel Service Finally Turning the Corner?
- Taiwan Semiconductor Flexes Pricing Power on AI’s Frontline
- Hidden in Plain Sight: 2 Earnings Winners Investors May Have Missed
- These 3 New ETFs Are Turning Heads—Are They Worth Buying?
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
